Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma

NCT04602013 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Sintilimab
DRUG: Chemotherapy
RADIATION: Radiation Therapy

Sponsor

Sichuan Cancer Hospital and Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]